Memorial Sloan Kettering Cancer Center (All protocol activities)
Memorial Sloan Kettering Cancer Center (All protocol activities)
New York, New York, United States2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer | cancer, neoplasm | Active, not recruiting | Phase 3 | 2026-08-05 | NCT01579552 | |
| Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Sezary syndrome, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mycosis fungoides, neoplasm, primary cutaneous T-cell non-Hodgkin lymphoma | Active, not recruiting | Phase 2 | 2026-06-12 | NCT04960618 |